These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34395251)

  • 1. The Evolving Role of
    Shen K; Liu B; Zhou X; Ji Y; Chen L; Wang Q; Xue W
    Front Oncol; 2021; 11():683793. PubMed ID: 34395251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Medina-Ornelas S; García-Perez F; Estrada-Lobato E; Ochoa-Carrillo F
    Am J Nucl Med Mol Imaging; 2020; 10(3):135-142. PubMed ID: 32704404
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Xu L; Chen R; Yu X; Liu J; Wang Y
    Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of
    Chen R; Wang Y; Shi Y; Zhu Y; Xu L; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2970-2977. PubMed ID: 33528607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
    Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ
    BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT.
    Lütje S; Gomez B; Cohnen J; Umutlu L; Gotthardt M; Poeppel TD; Bockisch A; Rosenbaum-Krumme S
    Clin Nucl Med; 2017 Jan; 42(1):20-25. PubMed ID: 27846003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
    Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
    Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of [
    Uprimny C; Svirydenka A; Fritz J; Kroiss AS; Nilica B; Decristoforo C; Haubner R; von Guggenberg E; Buxbaum S; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1873-1883. PubMed ID: 29766246
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
    J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of
    Shi Y; Xu L; Zhu Y; Wang Y; Chen R; Liu J
    Front Oncol; 2021; 11():646110. PubMed ID: 33777806
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of gallium-68 prostate-specific membrane antigen PET/CT and 2-[18F]fluoro-2-deoxy-D-glucose PET/CT in the detection of thyroid cancer lesions: a prospective head-to-head comparison.
    Shi Y; Feng Y; Xu L; Li W; Guan L; Zuo R; Liu S; Pang H; Wang Z
    Br J Radiol; 2023 Jul; ():. PubMed ID: 38904463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection Rate of
    Jilg CA; Drendel V; Rischke HC; Beck TI; Reichel K; Krönig M; Wetterauer U; Schultze-Seemann W; Meyer PT; Vach W
    J Nucl Med; 2019 Jul; 60(7):971-977. PubMed ID: 30683768
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Oliveira JM; Gomes C; Faria DB; Vieira TS; Silva FA; Vale J; Pimentel FL
    World J Nucl Med; 2017; 16(1):3-7. PubMed ID: 28217012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Prostate Cancer Glucose Metabolism Detected by
    Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F
    Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Gündoğan C; Ergül N; Çakır MS; Kılıçkesmez Ö; Gürsu RU; Aksoy T; Çermik TF
    Mol Imaging Radionucl Ther; 2021 Jun; 30(2):79-85. PubMed ID: 34082503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target?
    Wächter S; Di Fazio P; Maurer E; Manoharan J; Keber C; Pfestroff A; Librizzi D; Bartsch DK; Luster M; Eilsberger F
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830843
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Pfister D; Haidl F; Nestler T; Verburg F; Schmidt M; Wittersheim M; Steib F; Heidenreich A
    BJU Int; 2020 Dec; 126(6):679-683. PubMed ID: 32531840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.